Long-circulating liposomal contrast agents for magnetic resonance imaging

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Radiology

Background:

• Contrast-enhanced magnetic resonance imaging (CE-MRI) is vital for vascular imaging.
• Current gadolinium (Gd) chelates have short blood circulation times and rapid extravascular diffusion, limiting imaging windows for techniques like MR angiography (MRA).

Purpose of the Study:

• To develop and characterize long-circulating, polyethylene glycol-bearing (PEGylated) liposomes encapsulating Gd chelates for improved MRA.
• To evaluate the utility of these novel liposomal formulations in a preclinical setting.

Main Methods:

• Liposomes were prepared by hydrating lipids with gadodiamide (Omniscan).
• Liposomes were sized to approximately 100 nm using an extruder and purified via dialysis to remove unencapsulated Gd.
• The efficacy of the Gd-loaded liposomes was assessed using MRI in a rat model.

Main Results:

• The PEGylated Gd liposomes demonstrated sustained contrast enhancement of vasculature for over 4 hours.
• Improved spatial details were observed in MRA compared to conventional Gd-DTPA.
• Minimal leakage into the extravascular space was noted, unlike Gd-DTPA controls.

Conclusions:

• Long-circulating liposomal Gd formulations enable steady-state imaging for MRA.
• These novel agents overcome limitations of rapid clearance and extravascular diffusion associated with traditional Gd chelates.
• PEGylated liposomes offer potential for high-resolution vascular imaging with reduced artifacts.